Skip To Content


Open conversations, knowledge sharing, and fresh ideas promote positive change and transparency

Thought leadership

Read more

Leader Perspective

Read more


Read more


Read more

Our latest blog posts, articles and podcasts 

Sharing information with the industry is an important part of our mission. Our subject matter experts translate today’s news into comprehensive informational pieces to help you better understand the impact of a recent industry update, trend, or issue.

February 28, 2024 · Public Policy & Regulatory Affairs Team
California corrects drug formulary, Kentucky introduces several work comp bills, Wisconsin bill would establish a work comp medical fee schedule, New York enhances prior auth portal, several other states introduce work comp firefighter coverage and presumption bills, and New Mexico eyes study on treatment with mushrooms Read more...
February 07, 2024 · Public Policy & Regulatory Affairs Team
California and Ohio update their work comp drug formularies, while New Jersey expands presumptive coverage for first responders and introduces several new work comp and auto no-fault bills. Read more...
January 29, 2024 · Medicare Insights Team
Recent CMS webinar clarifies final rule on civil money penalties for Non-Group Health Plans, describing the triggers for reporting and the auditing process, emphasizing that RREs are required to report claims and that the penalties apply only to prospective claims, and distinguishing between informal and formal notices. Read more...
January 25, 2024 · Optum Workers' Comp and Auto No-Fault
Stacey McKee has always championed excellence in customer service. With over two decades of managed care, account management, and sales experience, Stacey knows that each client faces varied and specific challenges. Read more...
January 18, 2024 · By: Courtney DuChene, Risk & Insurance
One way workers’ comp and auto no-fault payers can ensure that their patients are getting the best care possible is by partnering with a PBM that works with pharmacists from a wide array of clinical backgrounds Read more...
January 17, 2024 · Clinical Team
The U.S. Food and Drug Administration (FDA) reported that Dr. Reddy’s voluntarily recalled one lot of tizanidine 4 mg tablets at the consumer level as a precautionary measure. Tizanidine is a skeletal muscle relaxant commonly prescribed for the treatment of muscle spasticity. Read more...
     Next >>
Page 1 of 7